Former President Joe Biden has been diagnosed with an “aggressive” form of prostate cancer that has spread to his bones. But ...

The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year ...

Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...

The idea that a man could receive regular exams and still wind up with a late-stage discovery? It doesn’t surprise me at all.

Donn Young is the former director of the Ohio State University Comprehensive Cancer Center Biostatistics Unit where he spent 32 years designing, conducting, and analyzing cancer research studies. Like ...

A Gleason score of 8–10 indicates a highly aggressive prostate cancer that will likely grow quickly. In Australia, 67.9% of ...

A newly identified mutation dramatically raises prostate cancer risk in Ashkenazi Jewish men and may increase sensitivity to ...

Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But ...

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

Developing tests that better identify patients at risk of dying from prostate cancer can decrease overtreatment. In the ...